---
title: "ETON.US (ETON.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ETON.US/news.md"
symbol: "ETON.US"
name: "ETON.US"
parent: "https://longbridge.com/en/quote/ETON.US.md"
datetime: "2026-05-20T11:52:38.763Z"
locales:
  - [en](https://longbridge.com/en/quote/ETON.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ETON.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ETON.US/news.md)
---

# ETON.US (ETON.US) — Related News

### [Eton Pharmaceuticals Adds Another 2026 Launch As It Secures U.S. Rights To IMPAVIDO](https://longbridge.com/en/news/287025596.md)
*2026-05-20T07:45:15.000Z*
> Eton Pharmaceuticals has secured exclusive U.S. rights to IMPAVIDO, the only FDA-approved oral therapy for leishmaniasis

### [Eton Secures U.S. IMPAVIDO Rights; $4.25M Fees, Up To $4M Milestones And 50-55% Revenue Share](https://longbridge.com/en/news/286966420.md)
*2026-05-19T20:53:01.000Z*
> Eton Pharmaceuticals has secured exclusive U.S. commercialization rights for IMPAVIDO, agreeing to pay $4.25 million in 

### [Full Transcript: Eton Pharmaceuticals Q1 2026 Earnings Call](https://longbridge.com/en/news/286472130.md)
*2026-05-14T21:27:35.000Z*
> Eton Pharmaceuticals reported a 73% year-over-year increase in product revenue, reaching $24 million in Q1 2026. The com

### [Eton Pharmaceuticals | 10-Q: FY2026 Q1 Revenue Beats Estimate at USD 24.27 M](https://longbridge.com/en/news/286464310.md)
*2026-05-14T20:33:33.000Z*
### [Eton Pharmaceuticals | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 24.27 M](https://longbridge.com/en/news/286464237.md)
*2026-05-14T20:33:07.000Z*
### [H.C. Wainwright Remains a Buy on Eton Pharmaceuticals (ETON)](https://longbridge.com/en/news/286220698.md)
*2026-05-13T08:07:46.000Z*
> H.C. Wainwright analyst Swayampakula Ramakanth has maintained a Buy rating on Eton Pharmaceuticals (ETON) with a price t

### [Eton Pharmaceuticals to Participate in Upcoming Investor Conferences](https://longbridge.com/en/news/286156050.md)
*2026-05-12T20:32:00.000Z*
> On May 12, 2026, in Deer Park, Illinois, Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a pharmaceutical company specializin